Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Receivables: 2016-2024

Historic Change in Receivables for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to $415,000.

  • Whitehawk Therapeutics' Change in Receivables rose 280.18% to $1.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.0 million, marking a year-over-year increase of 411.71%. This contributed to the annual value of $415,000 for FY2024, which is 88.55% down from last year.
  • As of FY2024, Whitehawk Therapeutics' Change in Receivables stood at $415,000, which was down 88.55% from $3.6 million recorded in FY2023.
  • Whitehawk Therapeutics' 5-year Change in Receivables high stood at $13.9 million for FY2020, and its period low was -$14.1 million during FY2021.
  • In the last 3 years, Whitehawk Therapeutics' Change in Receivables had a median value of $1.9 million in 2022 and averaged $2.0 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first slumped by 202.06% in 2021, then surged by 113.16% in 2022.
  • Yearly analysis of 5 years shows Whitehawk Therapeutics' Change in Receivables stood at $13.9 million in 2020, then tumbled by 202.06% to -$14.1 million in 2021, then soared by 113.16% to $1.9 million in 2022, then skyrocketed by 94.74% to $3.6 million in 2023, then plummeted by 88.55% to $415,000 in 2024.